Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Collegium Pharmaceutical Stock Is Crushing It Today

TheMotleyFool

0 0

Why Collegium Pharmaceutical Stock Is Crushing It TodayPhoto, wide shot, wide-angle lens, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png

Shares of Collegium Pharmaceutical (NASDAQ: COLL) were soaring 33.7% higher as of 11:12 a.m. EST on Thursday. This big jump came following the small drugmaker's third-quarter update after the market closed on Wednesday.

Collegium missed Wall Street estimates on both its top and bottom lines. However, the company announced exclusive formulary deals for its abuse-deterrent Xtampza ER opioid painkiller that will cover more than 35 million lives beginning in January 2020.

Image source: Getty Images.

Source Fool.com

Like: 0

COLL

Share